Investigation of the Mechanism of Action of Anti-PD-1 Treatment by Systematic Depletion of Different Immune Cell Populations in Syngeneic Models
Thursday 12 December, 12:15-13:15 and on display throughout the Congress
Presented by Dr Ludovic Bourre, Senior Director, Scientific Engagement
Explore how different immune cell lineages impact anti-PD-1 efficacy, through combination of anti-PD-1 treatment with depletion of different immune cell populations across a panel of syngeneic models. Understand more about anti-PD-1 mechanism of action through deep proteomic analysis of tumour samples.